Exchange Written Premium Climbs 27% to $1.33B as Thoma Bravo Deal Slips to H1 2027
ARX has more than doubled off its 52-week low of $9.18 on light trading volume (0.3× avg).
Summary
Accelerant posted Q3 operating revenue of $278.6M, a loss per share of 6c and adjusted EBITDA of $71.3M, with Exchange Written Premium up 27% year over year to $1.33B. Fee-based adjusted EBITDA, defined as consolidated results less the Underwriting segment, rose 75% to $84.5M — the strongest growth line in the release. The company gave no year-over-year comparisons for revenue or adjusted EBITDA, so the quality of the headline premium growth is hard to grade from this release alone. Management now expects the $20.25-per-share Thoma Bravo cash sale to close in the first half of 2027, later than the timeline implied, and will not provide Q4 or FY2026 guidance. With the stock near its 52-week high, the deal timeline and the absence of forward guidance matter more than the quarterly print.
At the time of this announcement, ARX was trading at $19.87 on NYSE in the Finance sector, with a market capitalization of approximately $4.3B. The 52-week trading range was $9.18 to $19.91. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.